期刊文献+

经直肠能量多普勒超声在前列腺穿刺活检中的临床价值 被引量:4

Clinical value of prostatic biopsy under the guidance of transrectal power Doppler ultrasonography
下载PDF
导出
摘要 目的:探讨经直肠能量多普勒超声(PDU)在前列腺穿刺活检中的临床应用价值,提高前列腺癌的诊断率。方法:对临床高度怀疑前列腺癌的54例病人在穿刺前完成经直肠二维灰阶超声的常规检查、PDU检查,根据检查结果选择经直肠二维灰阶超声、PDU及两者联合使用靶向穿刺结合6点前列腺系统穿刺活检方案。对比分析直肠二维灰阶超声、PDU靶向穿刺活检诊断前列腺癌的敏感性、特异性、阳性预测值、阴性预测值。结果:经直肠PDU检查发现异常血流增多37例,其中前列腺癌23例(包括2例为灰阶超声无异常发现的位于外腺的前列腺癌),前列腺增生症11例,前列腺癌不能除外1例,前列腺占位1例(未定),转移性前列腺癌1例(膀胱癌)。结论:经直肠PDU能提高前列腺癌检测的敏感性与定位适合穿刺点,经直肠PDU靶向穿刺活检病理Gleason评分更高。 Objective: To evaluate the clinical value of transrectal power Doppler uhrasonography (PDU) and PDU-directed prostatic biopsy to improve the diagnosis of prostatic cancer. Methods: Fifly-four patients suspected to be prostatic cancer underwent routine gray-seale TRUS, transreetal PDU of the entire gland before biopsy. According to the result, select the protocols of gray-scale TRUS, transreetal PDU and combined use of six-score transrectal biopsy protocols. The sensitivity, specificity, positive predictive value, negative predietive value were compared and analyzed. Results: Abnormal flow was detected by power Doppler scanning in 37 patients, among them 23 cases were of prostatic cancer (two of them were normal on grayscale image), BPH in 11 cases, prostatic cancer cannot be ruled out in 1 case, prostatic mass of undetermined nature in 1 case, metastatic prostatic cancer of bladder origin in 1 case. Conclusions: Transrectal PDU ean improve the sensitivity of cancer detection, and can determine the correct site for PDU-direeted biopsy, the Gleason score is significantly higher.
出处 《中国临床医学影像杂志》 CAS 北大核心 2009年第2期100-102,共3页 Journal of China Clinic Medical Imaging
关键词 前列腺肿瘤 活组织检查 针吸 超声检查 多普勒 彩色 Prostatic neoplasms Biopsy, needle: Uhrasonography, Doppler, color
  • 相关文献

参考文献8

  • 1Okihara K, Kojima M, Nakanouchi T, et al. Transrectal power Doppler imaging in the detection of prostate cancer [J]. BJU Int, 2000, 85: 1053-1057.
  • 2白亮,王行环,胡礼泉.特异性抗原密度联合前列腺穿刺活检诊断前列腺癌的价值[J].临床泌尿外科杂志,2004,19(4):205-207. 被引量:9
  • 3Eskicorapci SY, Baydar DE. Akbal C, et al. An extended 10 core transrectal uhrasonography-guided prostate biopsy protocol improves the detection of prostate cancer [J]. Eur Urol, 2004, 45: 444-448.
  • 4Jones JS, Patel A, Schoenfield L, et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy [J]. J Urol, 2006, 175(2): 485-488.
  • 5Stephen JJ, Mehmet O, Craig ZD. Saturation prostate biopsy with periprostatic block can be performed in office [J]. J Urol, 2002, 168(5): 2108-2110.
  • 6Sauvain JL Palascak P, Bremon JM. Power Doppler ultrasonography and hypoechoic nodules of the peripheral prostate: perspectives and limitations[J]. J Radiol, 1997, 78: 491-497.
  • 7Eventis AK, Shariat SF, Utsunomiya T, et al. Characteristics of normal prostate vascular anatomy as displayed by power Doppler [J]. Prostate, 2001, 46(4): 251-288.
  • 8Cho JY, Kim SH, Lee SE. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound[J]. Eur Urol, 2000, 37(4): 443-448.

二级参考文献7

  • 1Kurita Y, Suzuki A, Masuda H, et al. Transition zone volume-adjusted prostate-specific antigen value predicts extracapsular carcinoma of the prostate in patients with intermediate prostate-specific antigen levels. Europe Urology, 1998, 33:32-38.
  • 2Horninger W, Reissigl A, Klocker H, et al. Improvement of specificity in PSA-based screening by using PSA-trasition zone density and percent free PSA in addition to total PSA levels. Prostate, 1998, 37: 133-137.
  • 3Moon D G, Yu J W, Lee J G, et al. The influence of prostate volume on the prostate-specific antigen(PSA) level adjusted for the transition zone volume and free-tototal PSA ratio: aprospective study. BJU-Int, 2000,86:670-674.
  • 4Mc Neal J E. The prostate gland, morphology and pathobiology. Monegr Urology, 1988, 9:36-54.
  • 5Serdar M A, Ognz O, Olgun A, et al. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together. Ann-Clin-Lab-Sci,2002, 32:22-30.
  • 6MoonDG, Cheon J, KimJ J, et al. Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer. Iht J Urol, 1999, 6:455-462.
  • 7Ehreth J T, Miller J I, McBeach R B, et al. Prostatespecific antigen obtained under optimal conditions determines extracapsular adenocarcinoma of the prostate. BrJ Urol, 1995, 75:21-25.

共引文献8

同被引文献71

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部